Parkville, Australia

Angus Cowan

This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Anaxis Pharma Pty Ltd. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Angus Cowan. Retrieved from https://idiyas.com/inventor/angus-cowan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Angus Cowan and Sulphonamide Compounds.

Introduction

Angus Cowan is an inventor associated with Parkville, Australia, and Anaxis Pharma Pty Ltd. His patent work concerns sulphonamide compounds and their potential role in addressing necroptosis and MLKL activity.

Latest Patents

Cowan is associated with 1 patent, titled “Sulphonamide compounds.” The invention describes compounds of formula (I), along with their salts, solvates, tautomers, N-oxides, stereoisomers, polymorphs, and prodrugs. It also discloses using these compounds to treat necroptosis and/or inhibit MLKL.

Career Highlights

Cowan’s listed patent reflects research into compounds with potential applications in biological pathways involving necroptosis and MLKL. He is associated with Anaxis Pharma Pty Ltd.

Collaborations

Cowan’s listed coworkers include Martin Brzozowski and Guillaume Laurent Lessene.

Conclusion

Angus Cowan’s patent activity centers on sulphonamide compounds and their proposed use in treating necroptosis and inhibiting MLKL.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…